10Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).JAMA,2001,285(19):2 486-2 497.
1Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量：117
2叶任高.内科学[M]5版.北京:人民卫生出版社,2001.258.
3Nakazato R,Gransar H,Berman DS,et al.Statins use and coronary artery plaque composition:results from the Inter- national Multicenter CONFIRM Registry[J].Atherosclero- sis, 2012,225 ( 1 ) : 148-153.
4Cherkanova MS,Korolenko TA,Brawe IY,et aLEffect of statins on activity of matrix metalloproteases and serum concentration of cystatin C in patients with various risk of development of ischemic heart disease and in patients af- ter coronary artery by pass surgery[J].Kardiologiya ,2012, 52(2) :23-28.
5Sasaki J,Yokoyama M,Matsuzaki M,et al.Relationship between coronary artery disease and non-HDL-C,and ef- fect of highly purified EPA on the risk of coronary artery disease in hypercholesterolemic patients treated with statins: sub-analysis of the Japan EPA Lipid Intervention Study(JELIS)[J].J Atheroscler Thromb ,2012,19(2) : 194- 204.
7Assessment R. Major lipids, apolipoproteins, and risk of vascular disease[J]. Journal of the American Medical Association,2009, 302( 18 ) : 1993-2000.
8Bgulliksson M, Burell G, Vessby B, et al. Randomized controlled trim of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM) [ J ]. Archives of Internal Medicine, 2011,171 (2) :134-140.
